Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Translating Germline Cancer Risk into Precision Prevention.

Yurgelun, Matthew B; Chenevix-Trench, Georgia; Lippman, Scott M.
Cell; 168(4): 566-570, 2017 02 09.
Artigo em Inglês | MEDLINE | ID: mdl-28187278
Study of the biology of tumors caused by germline mutations has led to recent paradigm-changing therapy and is driving precision prevention efforts, including immune oncology and early detection research. Here, we explore recent biologic advances that are redefining the spectrum of cancers linked to various hereditary predisposition syndromes and can be leveraged to improve personalized risk assessment and develop novel interventions to prevent or intercept cancer.
Selo DaSilva